欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2003, Vol. 8 ›› Issue (4): 428-430.

• 研究原著 • 上一篇    下一篇

缬沙坦对盐敏感性高血压患者血压及血管紧张素Ⅱ和醛固酮水平的干预作用

胡立群, 蔡其云, 王卫东, 刘骏   

  1. 安徽省立医院干部病房心内科,合肥 230001,安徽
  • 收稿日期:2002-11-08 修回日期:2003-02-21 出版日期:2003-08-26 发布日期:2020-11-19
  • 通讯作者: 胡立群,男,医学硕士,副主任医师,研究方向为老年心血管病。Tel:0551-5119636  E-mail:HLQ_1963@sina.com

Interference of valsartan on bloodPressure andPlasma angiotensinⅡ , aldosterone in salt sensitive essential hypertensivePatients

HUli-Qun, CAI Qi-Yun, WANG Wei-Dong, lIU Jun   

  1. Department of Cardiology,leader Ward,AnhuiProvince Hospital,Hefei 230001,Anhui,China
  • Received:2002-11-08 Revised:2003-02-21 Online:2003-08-26 Published:2020-11-19

摘要: 目的 探讨选择性血管紧张素Ⅱ受体(AT1)拮抗剂对盐敏感性高血压患者血压,血管紧张素Ⅱ(AngⅡ)和醛固酮(ALD)水平的干预作用。方法 对84 例原发性高血压患者用静脉盐水负荷法确定盐敏感性,并观察应用缬沙坦后血压及血清AngⅡ和ALD 水平的变化。结果 原发性高血压盐敏感组与非盐敏感组在应用缬沙坦治疗2 、4 、6 、8 wk 后坐位收缩压分别下降了17.5±4.3 、11.0±1.4 mmHg 坐位舒张压下降了17.0±3.7 、7.7±1.1 mmHg,有显著的统计学意义(P<0.001)。用药后,两组患者血浆AngⅡ水平均明显升高,ALD 水平显著下降。结论 缬沙坦对原发性高血压患者盐敏感组与非盐敏感组均有较好的降压作用,而对盐敏感组的降压作用更显著,且对二组患者血浆AngⅡ和ALD 水平有一定的干预作用。

关键词: 药效学, 缬沙坦, 盐敏感性, 高血压, 血管紧张素Ⅱ, 醛固酮

Abstract: AIM: To investigate the interference of valsartan on bloodPressure andPlasma angiotensinⅡ(angⅡ),aldosterone(ALD)in salt sensitive essential hypertensivePatients.METHODS: Eighty-four adult hypertensivePatients were enrolled in study,and the salt sensitivity was determined by acute intravenous salt waterloading according to Sullvan' s criteria.The change of bloodPressure andPlasma angⅡ,and ALD were compared before and after the treatment.RESULTS: At the end of 2,4,6,and 8 weeks,patients with salt sensitive essential hypertensive(grouPss)and no salt sensitive essential hypertensive(grouPnss)were measured.The results showed that sitting systolic bloodPressure(SiSBP)was decreased by 17.5±4.3 and 11.0±1.4 mmHg,and sitting diastolis bloodPressure(SiDSP)was decreased by 17.0±3.7 and 7.3±1.1 mmHg after the treatment.It was found thatPatients showed significantly higherPlasma angⅡ andlowerPlasma ALD in grouPss and grouPnss.CONCLUSION: Valsartan can significantly control SiSBPand SiDBPfor both groups,interferedPlasma angiotensinⅡ and I aldosterone,and be more effective forPatients with salt sensitive essential hypertensive.

Key words: pharmacodynamics, valsartan, salt sensitive, hypertensive, angiotensinⅡ, aldosterone

中图分类号: